m-RESIST
01. About the project
Framework: Horizon 2020. PHC-26-2014, Grant Agreement 643552.
Funding: 4.034.222 €
02. Description
m-RESIST (Mobile Therapeutic Attention for Pacients with Treatment Resistant Schizophrenia) is a European project that developed a therapeutic procedure supported by mobile devices. Involving actively patients with resistant Schizophrenia treatment and their caregivers. Both patients and caregivers could manage the pathology themselves. m-RESIST implemented an analytic model in order to advance in the understanding of the resistant scizophrenia and predict behavioural issues of the illness. The m-RESIST solution has been tested in 3 pilots with real users carried out between Catalonia, Israel and Hungary.
It established a reaction alarm system, protocols and recommendations to support the professional in the clinical decisions.
03. Consortium
- TIC Salut Social Foundation
- Fundació Institut de Recerca del Hospital de la Santa Creu i Sant Pau
- Parc Sanitari Sant Joan de Deu (PSSJD)
- The Gertner Institute for Epidemiology and Health Policy Research
- University of Oulu
- iMec
- IBM Global Services España S.A.
- ATHENS TECHNOLOGY CENTER S.A.
- Semmelweis University
- Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
- Ab.Acus srl
- Institute of Communication and Computer Systems (ICCS)
